Vjs Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.03 M
as on 24-12-2024
- Paid Up Capital ₹ 1.03 M
as on 24-12-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Satisfied Charges ₹ 1.55 Cr
as on 24-12-2024
- Revenue -8.96%
(FY 2020)
- Profit 111.51%
(FY 2020)
- Ebitda 21.22%
(FY 2020)
- Net Worth 26.93%
(FY 2020)
- Total Assets -26.85%
(FY 2020)
About Vjs Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.03 M and a paid-up capital of Rs 1.03 M.
The company has closed loans amounting to ₹1.55 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Tarkeshwar Tiwari and Indu Shukla serve as directors at the Company.
- CIN/LLPIN
U24100DL2010PTC199775
- Company No.
199775
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Mar 2010
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vjs Pharmaceuticals Private Limited offer?
Vjs Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Vjs Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarkeshwar Tiwari  | Additional Director | 22-Aug-2020 | Current |
| Indu Shukla | Director | 08-Mar-2010 | Current |
Financial Performance of Vjs Pharmaceuticals.
Vjs Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.96% decrease. The company also saw a substantial improvement in profitability, with a 111.51% increase in profit. The company's net worth Soared by an impressive increase of 26.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vjs Pharmaceuticals?
In 2020, Vjs Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vjs Global Business Networks Private LimitedActive 4 years 4 monthsTarkeshwar Tiwari and Indu Shukla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 17 Nov 2014 | ₹0.48 M | Satisfied |
Rajendra Place Branch, Rachna Cinema Building, Creation Date: 27 Dec 2012 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Vjs Pharmaceuticals?
Vjs Pharmaceuticals has a workforce of 1 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vjs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vjs Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
